Tokyo Tape
Sign in
5% STAKE4588.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Oncolys BioPharma to 4.31%

Stake history

0%5%10%15%20%15.19%PriorPrior: 15.19% · prior ratio stated in S100U4FX13.49%Aug 1Aug 1: 13.49% · S100U4FX11.97%Aug 14Aug 14: 11.97% · S100U7QJ11.05%Aug 21Aug 21: 11.05% · S100U9259.94%Sep 20Sep 20: 9.94% · S100UDNA7.93%Oct 18Oct 18: 7.93% · S100UJHL6.78%Oct 21Oct 21: 6.78% · S100UK2U5.24%Oct 22Oct 22: 5.24% · S100UKDW4.31%Oct 23Oct 23: 4.31% · S100UKHK
0%5%10%15%20%15.19%PriorPrior: 15.19% · prior ratio stated in S100U4FX13.49%Aug 1Aug 1: 13.49% · S100U4FX11.97%Aug 14Aug 14: 11.97% · S100U7QJ11.05%Aug 21Aug 21: 11.05% · S100U9259.94%Sep 20Sep 20: 9.94% · S100UDNA7.93%Oct 18Oct 18: 7.93% · S100UJHL6.78%Oct 21Oct 21: 6.78% · S100UK2U5.24%Oct 22Oct 22: 5.24% · S100UKDW4.31%Oct 23Oct 23: 4.31% · S100UKHK

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-10-23 10:42 JST concerning Oncolys BioPharma Inc. Reported holding ratio: 4.31%, previous report: 5.24%.

Stock price4588 · View chart ↗

Open the price chart on TradingView.

Source: EDINET S100UKHK ↗ · PDL1.0 · Not investment advice